Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
228.00    -1.50 (-0.65%)
Bid:
227.00
Ask:
227.50
Spread: 0.50 (0.22%)
Market Cap: £630.23m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Trading Update

12 Nov 2015 07:00

RNS Number : 4277F
Morgan Advanced Materials PLC
12 November 2015
 



 

Press Release

Trading Update

Morgan Advanced Materials plc

12th November 2015

 

 

Morgan Advanced Materials plc, the advanced materials company, is today issuing the following trading update covering the period from 1st July 2015 to 11th November 2015.

 

Trading conditions in the period since the half year have weakened across the Group with North America and China particularly affected by deteriorating demand. Overall our order book has mirrored this weakness, but with a mixed profile across the geographies, businesses and end markets in which we operate.

 

At the end of October the YTD book to bill ratio was 1.00 (June 2015 -1.03). The outstanding order book at the end of October was 5.3% below last year (June 2015 - 5.7% higher than the June 2014). Given this order profile, the Group expects that reported revenue in the second half of the year will be c7% below the first half of 2015 and that EBITA before restructuring and one-offs will be around the lower end of the range of analyst expectations.

 

The North American region has been the most affected by economic slowdown. General industrial demand weakness has been seen across our business over the last four months particularly oil and gas, transportation and mining markets.

 

In Europe the Thermal Ceramics business has continued to trade well, offset by weak demand in Technical Ceramics, Seals and Bearings and Composites and Defence Systems.

 

Asia/ROW has continued to see very weak demand in China, which has impacted both the products manufactured in-region for industrial markets and also those sold in to China from Morgan businesses in North America and Europe. The rest of Asia has shown some weakness in parts of its demand environment, but overall has been fairly resilient. Weak economic conditions in South America, particularly in Brazil and Argentina, are impacting the performance of our mainly industrial business in the region.

 

The Group is cautious about the trading and macro-economic environment for the rest of this year, and into 2016, and the Group has undertaken a range of cost reduction measures in line with this weakening economic environment and will continue to take further action as necessary. The cash cost for these restructuring and one-off items is estimated to be low, in the region of £3 million. Against this challenging market, the Group continues to invest in R&D and profitable growth opportunities which are critical for the future. Such investment is underpinned by solid cash flow and a strong balance sheet, with low net debt estimated to be c1.5 times EBITDA at the end of 2015.

 

Morgan's preliminary results for the year ended 31st December 2015 will be announced on 23rd February 2016.

 

(Note:

Current market expectations compiled from analyst notes for EBITA before restructuring and one-off items range from £110.0 million to £121.5 million).

 

 

 

 

 

 

For further enquiries:

 

Pete Raby/Kevin Dangerfield

Morgan Advanced Materials plc

01753 837000

Mike Smith/Nina Coad

Brunswick

0207 404 5959

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKDDDFBDDODD
Date   Source Headline
23rd Mar 202211:01 amRNSDirector/PDMR Shareholding
22nd Mar 20225:04 pmRNSDirector/PDMR Shareholding
4th Mar 20227:00 amRNSFull-year results
10th Jan 202211:30 amRNSHolding(s) in Company
15th Dec 202110:00 amRNSBlock listing Interim Review
7th Dec 202112:30 pmRNSHolding in Company
26th Nov 20213:32 pmRNSDirector/PDMR Shareholding
23rd Nov 20212:00 pmRNSDirector/PDMR Shareholding
5th Nov 20217:00 amRNSTrading Update
18th Oct 202112:21 pmRNSDirector/PDMR Shareholding
18th Oct 202112:20 pmRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSCFO Appointment
14th Oct 20219:15 amRNSHolding in Company
11th Oct 202110:45 amRNSHolding in Company
28th Sep 20213:15 pmRNSDirector/PDMR Shareholding
17th Sep 20213:58 pmRNSDirector/PDMR Shareholding
16th Sep 202111:30 amRNSDirector/PDMR Shareholding
5th Aug 20211:39 pmRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSHalf-year Results
15th Jun 20219:38 amRNSBlock Listing Interim Review
10th Jun 20219:18 amRNSDirector/PDMR Shareholding
27th May 20214:02 pmRNSDirector/PDMR Shareholding
25th May 20213:38 pmRNSDirector/PDMR Shareholding
11th May 202110:20 amRNSDirector/PDMR Shareholding
6th May 202111:54 amRNSResult of AGM
6th May 20217:00 amRNSDirectorate Change
6th May 20217:00 amRNSTrading Update
31st Mar 20212:08 pmRNSAnnual Financial Report
26th Mar 20219:54 amRNSHolding(s) in Company
24th Mar 202110:10 amRNSDirector/PDMR Shareholding
24th Mar 202110:08 amRNSDirector/PDMR Shareholding
24th Mar 202110:06 amRNSDirector/PDMR Shareholding
24th Mar 202110:05 amRNSDirector/PDMR Shareholding
4th Mar 202111:22 amRNSHolding(s) in Company
4th Mar 20217:00 amRNSFinal Results
15th Dec 202012:34 pmRNSBlock listing Interim Review
6th Nov 20207:00 amRNSQ3 Trading Update
16th Oct 20202:11 pmRNSDirector/PDMR Shareholding
6th Oct 20201:40 pmRNSDirector/PDMR Shareholding
28th Sep 20209:33 amRNSDirector Declaration
28th Sep 20209:19 amRNSDirector/PDMR Shareholding
1st Sep 20207:00 amRNSMorgan Advanced Materials announces divestment
10th Aug 202011:15 amRNSDirector/PDMR Shareholding
5th Aug 20205:16 pmRNSHolding(s) in Company
30th Jul 20207:00 amRNSHalf-Year Results
15th Jun 20204:09 pmRNSBlock listing Interim Review
15th Jun 20203:09 pmRNSHolding(s) in Company
5th Jun 20207:00 amRNSCOVID-19 update
20th May 20201:58 pmRNSDirector/PDMR Shareholding
7th May 20202:46 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.